Nightingale Health's mission is to build sustainable healthcare and reduce health inequalities. The company has developed the world's most advanced health check for the healthcare industry, providing risk detection for multiple chronic diseases from a single blood sample. Their solution can be scaled to entire populations at low cost, replacing many current risk assessments. This allows effective targeting and tracking of health interventions and better prevention of chronic diseases. Nightingale Health operates globally with a parent company in Finland and subsidiaries in Japan, the United States, Singapore, and the United Kingdom. They serve customers in over 25 countries in healthcare and medical research sectors, and their technology supports leading health initiatives like the UK Biobank, validated by over 600 peer-reviewed publications.

Nightingale Health was listed on Nasdaq Helsinki Main Market in 2025 and began trading on the OTCQX International Market in the US. They have collaborations with Kaiser Foundation, ZOE, Boston Heart Diagnostics, 23andMe, and Phenome Health, and expanded their lab operations to the UK and US. The company launched various new services and expanded internationally including in Japan and the US starting from 2013. They have won multiple awards and maintain a strong scientific advisory board and management team committed to healthcare innovation.

At Nightingale Health, employees are part of a mission to build a healthier tomorrow by transforming how chronic diseases are understood and prevented. The company values creativity, drive, and compassion and offers opportunities to contribute across various professional backgrounds worldwide. Open positions can be found on their careers page and they encourage applicants to join in shifting from reactive sick care to preventative healthcare.